Rhumbline Advisers Purchases 12,443 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
Rhumbline Advisers raised its position in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 16.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 89,560 shares of the company’s stock after purchasing an additional 12,443 shares during the period. […]
Rhumbline Advisers raised its position in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 16.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 89,560 shares of the company’s stock after purchasing an additional 12,443 shares during the period. […]
